49281-575-15 |
49281-575 |
HUMAN PRESCRIPTION DRUG |
BEYFORTUS |
nirsevimab |
INJECTION |
INTRAMUSCULAR |
20230718 |
N/A |
BLA |
BLA761328 |
Sanofi Pasteur Inc. |
NIRSEVIMAB |
100 mg/mL |
5 SYRINGE in 1 CARTON (49281-575-15) / .5 mL in 1 SYRINGE |
49281-575-00 |
49281-575 |
HUMAN PRESCRIPTION DRUG |
BEYFORTUS |
nirsevimab |
INJECTION |
INTRAMUSCULAR |
20230718 |
N/A |
BLA |
BLA761328 |
Sanofi Pasteur Inc. |
NIRSEVIMAB |
100 mg/mL |
1 SYRINGE in 1 CARTON (49281-575-00) / .5 mL in 1 SYRINGE |
49281-574-88 |
49281-574 |
HUMAN PRESCRIPTION DRUG |
BEYFORTUS |
nirsevimab |
INJECTION |
INTRAMUSCULAR |
20230718 |
N/A |
BLA |
BLA761328 |
Sanofi Pasteur Inc. |
NIRSEVIMAB |
100 mg/mL |
1 SYRINGE in 1 CARTON (49281-574-88) / 1 mL in 1 SYRINGE |
49281-574-15 |
49281-574 |
HUMAN PRESCRIPTION DRUG |
BEYFORTUS |
nirsevimab |
INJECTION |
INTRAMUSCULAR |
20230718 |
N/A |
BLA |
BLA761328 |
Sanofi Pasteur Inc. |
NIRSEVIMAB |
100 mg/mL |
5 SYRINGE in 1 CARTON (49281-574-15) / 1 mL in 1 SYRINGE |